Characteristics | Strong staining (n = 88) | Weak or absent staining (n = 106) | Total (n = 194) | P |
---|---|---|---|---|
Age | Â | Â | Â | Â |
   Median (range) | 45(25–70) | 46(14–72) | 45 (14–72) |  |
<50 | 58 | 65 | 123 | 0.408 |
≥50 | 30 | 41 | 71 |  |
Gender | Â | Â | Â | Â |
Female | 17 | 27 | 44 | 0.308 |
Male | 71 | 79 | 150 | Â |
Stage | Â | Â | Â | Â |
I/II | 21 | 39 | 60 | 0.052 |
III/IV | 67 | 67 | 134 | Â |
N stage | Â | Â | Â | Â |
N0 | 18 | 25 | 43 | 0.601 |
non-N0 | 70 | 81 | 151 | Â |
Metastasis (follow-up) | Â | Â | Â | Â |
Yes | 34 | 21 | 55 | 0.004 |
No | 54 | 85 | 139 | Â |